The remarks from Peter Marks, director of the Center for Biologics Evaluation and Research, came during a webinar as the FDA prepares to meet Oct. 14 and 15 with its outside advisers to discuss boosters for the Moderna and Johnson & Johnson vaccines.
J&J on Tuesday asked the FDA to grant emergency use authorization for a booster dose of its one-shot coronavirus vaccine, making it the third company to ask the Biden administration to approve additional doses.
Here’s what to know
Facebook Comments